[Medullary cancer of the thyroid].

Medullary thyroid cancer (MTC) is either of the sporadic or familial type, whether it be isolated or constitute part of a type II multiple endocrine neoplasia. Progress in the knowledge of the disease has recently been obtained in the following ways: the IRMA assay of mature calcitonin, the disease marker, has permitted earlier diagnosis of familial cases and recurrence; the locus assignment of the gene on chromosome 10 now enables a valid discrimination in certain families of gene carriers; collaborative clinical, biological, pathological, therapeutic and epidemiological research on a nation-wide scale has had a beneficial effect on patients, with improvement in diagnosis of the familial forms, in disease prognosis, in cancer detection at an infraclinical stage, and in the regrouping and distribution of families in France.
AuthorsC Calmettes
JournalBulletin du cancer (Bull Cancer) Vol. 77 Issue 11 Pg. 1063-72 ( 1990) ISSN: 0007-4551 [Print] FRANCE
Vernacular TitleCancer médullaire de la thyroïde.
PMID2275984 (Publication Type: English Abstract, Journal Article, Review)
  • Carcinoma (epidemiology, genetics, therapy)
  • Humans
  • Prognosis
  • Thyroid Neoplasms (epidemiology, genetics, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: